The largest database of trusted experimental protocols

Ions

Ions are electrically charged atoms or molecules that play crucial roles in various biological processes.
These charged particles can be positive (cations) or negative (anions), and they contribute to essential functions such as nerve impulse transmission, muscle contraction, and fluid balance regulation.
Ions are also involved in the structure and function of proteins, enzymes, and other biomolecules.
Understanding the role of ions in physiological and pathological conditions is a key focus of medical research, as imbalances in ion concentrations can lead to a wide range of health issues.
This MeSH term provides a comprehensive overview of the importance of ions in the human body and their impact on overall health and well-being.

Most cited protocols related to «Ions»

MD simulations of hen egg white lysozyme (HEWL), bovine pancreatic trypsin inhibitor (BPTI), ubiquitin (Ubq), and the B3 domain of Protein G (GB3) were performed using Desmond version 2.1.0.1 and the Amber ff99SB or the modified Amber ff99SB-ILDN force fields. The TIP3P water model20 was used for simulations of HEWL, Ubq, and GB3, and the TIP4P-Ew water model21 (link) was used for simulations of BPTI. Simulation parameters were the same as in the simulations of small helical peptides, apart from the fact that a 643 PME grid was used for HEWL and a 483 grid was used for BPTI, Ubq, and GB3. Simulations of HEWL, BPTI, Ubq, and GB3 were initiated from PDB22 (link) entries 6LYT, 5PTI, 1UBQ, and 1P7E solvated in cubic water boxes containing 10,594, 4215, 6080, and 5156 water molecules, respectively. The net charge of the proteins was neutralized with sodium or chloride ions. Each system was initially subject to energy minimization, followed by 1.2 ns of MD simulation in the NPT ensemble during which the temperature was increased linearly from 10 to 300 K, and position restraints on the backbone atoms were annealed from 1.0 to 0.0 kcal mol−1 Å−1. After this initial relaxation, each system was simulated for 6 ns in the NPT ensemble. The frame of this simulation with the volume closest to the average volume was selected as the starting conformation for a production run of 1.2 μs in the NVT ensemble. The trajectories obtained from the NVT runs were used for subsequent data analysis.
Full text: Click here
Publication 2010
Amber Aprotinin Chlorides Cuboid Bone Helix (Snails) hen egg lysozyme Ions Peptides Protein Domain Proteins Reading Frames Sodium Ubiquitin Vertebral Column
Protein simulation systems were prepared with the CHARMM-GUI.28 (link) Briefly, protein structures taken from corresponding protein data bank29 (link) files were solvated in pre-equilibrated cubic TIP3P water boxes of suitable sizes and counter-ions were added to keep systems neutral as detailed in Table 1. Periodic boundary conditions were applied and Lennard-Jones (LJ) interactions were truncated at 12 Å with a force switch smoothing function from 10 Å to 12 Å. The non-bonded interaction lists were generated with a distance cutoff of 16 Å and updated heuristically. Electrostatic interactions were calculated using the particle mesh Ewald method30 with a real space cutoff of 12 Å on an approximately 1 Å grid with 6th order spline. Covalent bonds to hydrogen atoms were constrained by SHAKE.31 After a 200 step Steepest Descent (SD) minimization with the protein fixed and another 200 steps without the protein fixed, the systems were first heated to 300 K and then subjected to a 100 ps NVT simulation followed by a 100 ps NPT simulation. The minimization, heating and initial equilibrium was performed with CHARMM,32 (link) and the resultant structures were used to start simulations in NAMD.33 (link) After a 1 ns NPT simulation as equilibration, the production simulations were run for 100 ns in the NVT ensemble (see Table 1). For HEWL NPT ensembles were generated to better compare with previous work that found CMAP helps to better reproduced order parameter S2,34 (link) and simulations were extended to 200 ns to reduce the uncertainty of the computed S2. Langevin thermostat with a damping factor of 5 ps−1 was used for NVT simulation and the Nosé-Hoover Langevin piston method with a barostat oscillation time scale of 200 fs was further applied for the NPT simulation at 300 K and 1 atm. The time step equals 2 fs and coordinates were stored every 10 ps. For each protein the above simulation protocol was applied with the C36 and C22/CMAP FFs, while for ubiquitin an additional 1.2 μs trajectories with C36 was generated. This long simulation is used to check the convergence and also to examine whether computed NMR data deteriorate over a longer simulation time, as it was reported that RDCs significantly deviate from experimental values after approximately 500 ns simulations with the C22 FF.22 (link)
Publication 2013
Cuboid Bone Electrostatics factor A Factor V Familial Mediterranean Fever Hydrogen Bonds Ions Proteins Ring dermoid of cornea Staphylococcal Protein A STEEP1 protein, human Tremor Ubiquitin
An Escherichia coli K12 strain was grown in standard LB medium, harvested, washed in PBS, and lysed in BugBuster (Novagen Merck Chemicals, Schwalbach, Germany) according to the manufacturer's protocol. HeLa S3 cells were grown in standard RPMI 1640 medium supplemented with glutamine, antibiotics, and 10% FBS. After being washed with PBS, cells were lysed in cold modified RIPA buffer (50 mm Tris-HCl, pH 7.5, 1 mm EDTA, 150 mm NaCl, 1% N-octylglycoside, 0.1% sodium deoxycholate, complete protease inhibitor mixture (Roche)) and incubated for 15 min on ice. Lysates were cleared by centrifugation, and after precipitation with chloroform/methanol, proteins were resuspended in 6 m urea, 2 m thiourea, 10 mm HEPES, pH 8.0. Prior to in-solution digestion, 60-μg protein samples from HeLa S3 lysates were spiked with either 10 μg or 30 μg of E. coli K12 lysates based on protein amount (Bradford assay). Both batches were reduced with dithiothreitol and alkylated with iodoacetamide. Proteins were digested with LysC (Wako Chemicals, GmbH, Neuss, Germany) for 4 h and then trypsin digested overnight (Promega, GmbH, Mannheim, Germany). Digestion was stopped by the addition of 2% trifluroacetic acid. Peptides were separated by isoelectric focusing into 24 fractions on a 3100 OFFGEL Fractionator (Agilent, GmbH, Böblingen, Germany) as described in Ref. 45 (link). Each fraction was purified with C18 StageTips (46 (link)) and analyzed via liquid chromatography combined with electrospray tandem mass spectrometry on an LTQ Orbitrap (Thermo Fisher) with lock mass calibration (47 (link)). All raw files were searched against the human and E. coli complete proteome sequences obtained from UniProt (version from January 2013) and a set of commonly observed contaminants. MS/MS spectra were filtered to contain at most eight peaks per 100 mass unit intervals. The initial MS mass tolerance was 20 ppm, and MS/MS fragment ions could deviate by up to 0.5 Da (48 (link)). For quantification, intensities can be determined alternatively as the full peak volume or as the intensity maximum over the retention time profile, and the latter method was used here as the default. Intensities of different isotopic peaks in an isotope pattern are always summed up for further analysis. MaxQuant offers a choice of the degree of uniqueness required in order for peptides to be included for quantification: “all peptides,” “only unique peptides,” and “unique plus razor peptides” (42 (link)). Here we chose the latter, because it is a good compromise between the two competing interests of using only peptides that undoubtedly belong to a protein and using as many peptide signals as possible. The distribution of peptide ions over fractions and samples is shown in supplemental Fig. S1.
Publication 2014
Acids Antibiotics, Antitubercular Biological Assay Buffers Cells Centrifugation Chloroform Cold Temperature Deoxycholic Acid, Monosodium Salt Digestion Dithiothreitol Edetic Acid Escherichia coli Escherichia coli K12 Glutamine HeLa Cells HEPES Homo sapiens Immune Tolerance Iodoacetamide Ions Isotopes Liquid Chromatography Methanol Peptides Promega Protease Inhibitors Proteins Proteome Radioimmunoprecipitation Assay Retention (Psychology) Sodium Chloride Staphylococcal Protein A Tandem Mass Spectrometry Thiourea Tromethamine Trypsin Urea
Simulations using Gromacs 4.5.3 were carried out for the following four folded globular proteins: bovine pancreatic trypsin inhibitor (BPTI), ubiquitin, GB3 and hen Lysozyme, starting from the published experimental structures (PDB entries 5PTI48 (link), 1UBQ49 (link), 1P7E50 (link), 6LYT51 respectively). Each protein was solvated in a truncated octahedron simulation cell filled with TIP3P water, with nearest distance between images of 45 Å for all proteins except for lysozyme, for which the distance was 60 Å. Sodium and chloride ions were added as needed to yield a final salt concentrations of ~100 mM, with adjustments to ensure charge neutrality. For each protein, a 100-step SD energy minimization of the whole system was performed, followed by 200 ps of MD at a constant pressure of 1 bar and temperature of 300 K, in which harmonic positional restraints of 2.39 kcal/mol/Å2 were applied to each Cartesian component of each protein non-hydrogen atom using the minimized structure as a reference. Each protein was then simulated at a constant pressure of 1 bar and a temperature of 300 K for 200 ns. Pressure was regulated by a Parinello-Rahman barostat52 with a coupling time of 2.5 ps; otherwise all details were as described for Ac-(AAQAA)3-NH2 above.
Publication 2012
A 300 Aprotinin Cells Chlorides Eye hen egg lysozyme Hydrogen Ions Muramidase Pressure Proteins Sodium Sodium Chloride Ubiquitin
Preparation of cDNA followed the procedure described in Mortazavi et al.2 (link), with minor modifications as described below. Prior to fragmentation, a 7 uL aliquot (∼ 500 pgs total mass) containing known concentrations of 7 “spiked in” control transcripts from A. thaliana and the lambda phage genome were added to a 100 ng aliquot of mRNA from each time point. This mixture was then fragmented to an average length of 200 nts by metal ion/heat catalyzed hydrolysis. The hydrolysis was performed in a 25 uL volume at 94°C for 90 seconds. The 5X hydrolyis buffer components are: 200 mM Tris acetate, pH 8.2, 500 mM potassium acetate and 150 mM magnesium acetate. After removal of hydrolysis ions by G50 Sephadex filtration (USA Scientific catalog # 1415-1602), the fragmented mRNA was random primed with hexamers and reverse-transcribed using the Super Script II cDNA synthesis kit (Invitrogen catalog # 11917010). After second strand synthesis, the cDNA went through end-repair and ligation reactions according to the Illumina ChIP-Seq genomic DNA preparation kit protocol (Illumina catalog # IP102-1001), using the paired end adapters and amplification primers (Illumina Catalog # PE102-1004). Ligation of the adapters adds 94 bases to the length of the cDNA molecules.
Publication 2010
Acetate Anabolism Bacteriophage lambda Buffers Chromatin Immunoprecipitation Sequencing DNA, Complementary DNA Chips Filtration Genome Hydrolysis Ions Ligation magnesium acetate Metals Oligonucleotide Primers Potassium Acetate RNA, Messenger sephadex Tromethamine

Most recents protocols related to «Ions»

Example 2

As discussed herein above, the disclosed methods improve the antiseptic properties of a dental implant without using charged metallic ions via conversion of the nitrogen moieties in titanium nitride surface to a positively charged quaternary ammonium via a Menschutkin reaction.

To prepare the antibacterial quaternized TiN surface, an implant which has been coated with TiN was used. The implant was cleaned to improve yield. The implant was washed with two solvents in sequence, acetone and isopropanol, to remove any dust particulate and other residue. The native oxide layer was removed by sonicating in 1:10 HCl:deionized water for 1 minute. This treatment additionally removes any residue that may not have been removed by the solvents. Acetonitrile was used as the solvent; however, any solvent may be used with preference for polar solvents giving improved reaction times (Stanger K., et al. J Org Chem. 2007 72(25):9663-8; Harfenist M., et al. J Am Chem Soc 1957 79(16):4356-4358). An excess of allyl bromide was added to the solvent and continuously stirred. The sample was then submerged in the solution, and full reaction of the surface occurred within about 60 minutes, as confirmed by contact angle measurement. A reference was also measured by submerging in solvent for the duration with no reactant to ensure any changes in surface properties was due to the quaternization.

TABLE 2
SampleContact Angle (°)
As-deposited TiN<6
In solvent 2 hrs (no reaction)16 ± 2
Allyl bromide 30 minutes67 ± 1
Allyl bromide 60 minutes72 ± 3
Allyl bromide 120 minutes71 ± 2

Without wishing to be bound by a particular theory, the increased hydrophobicity of the treated surfaces can be due to the presence of the allyl groups on the surface which will impart some hydrophobicity. The contact angle measurements provide information on whether or not a reaction has occurred and whether it has saturated.

The biocidal activity was tested using live bacteria cultures from a patient's mouth, which provides the full flora to act against rather than targeting an individual strain of bacteria. The bacteria was incubated on the sample surface using several bacteria film thicknesses. The thickness is defined by keeping the same interaction surface area while varying the volume of bacteria solution added. Across two separate patients and several separate growths, within 4 hours 40-50% reduction in bacteria unit counts were observed for quaternized TiN as compared to traditional Titanium implants, outperforming traditional TiN coatings. FIG. 4 shows for two separate patients a set of typical bacteria growth result of the quaternized samples. The exact efficiency varies, as each patient has different flora which varies depending on environmental factors such as hygiene, diet, and familial history.

Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of skill in the art to which the disclosed invention belongs. Publications cited herein and the materials for which they are cited are specifically incorporated by reference.

It will be apparent to those skilled in the art that various modifications and variations can be made in the present disclosure without departing from the scope or spirit of the disclosure. Other aspects of the disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the disclosure disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the disclosure being indicated by the following claims.

Full text: Click here
Patent 2024
Acetone acetonitrile allyl bromide Ammonium Anti-Bacterial Agents Anti-Infective Agents, Local Bacteria Diet Implant, Dental Ions Isopropyl Alcohol Metals Nitrogen Oral Cavity Oxides Patients Solvents Strains Surface Properties Titanium titanium nitride

Example 8

Characterization of Absorption, Distribution, Metabolism, and Excretion of Oral [14C]Vorasidenib with Concomitant Intravenous Microdose Administration of [13C315N3]Vorasidenib in Humans

Metabolite profiling and identification of vorasidenib (AG-881) was performed in plasma, urine, and fecal samples collected from five healthy subjects after a single 50-mg (100 μCi) oral dose of [14C]AG-881 and concomitant intravenous microdose of [13C3 15N3]AG-881.

Plasma samples collected at selected time points from 0 through 336 hour postdose were pooled across subjects to generate 0—to 72 and 96-336-hour area under the concentration-time curve (AUC)-representative samples. Urine and feces samples were pooled by subject to generate individual urine and fecal pools. Plasma, urine, and feces samples were extracted, as appropriate, the extracts were profiled using high performance liquid chromatography (HPLC), and metabolites were identified by liquid chromatography-mass spectrometry (LC-MS and/or LC-MS/MS) analysis and by comparison of retention time with reference standards, when available.

Due to low radioactivity in samples, plasma metabolite profiling was performed by using accelerator mass spectrometry (AMS). In plasma, AG-881 was accounted for 66.24 and 29.47% of the total radioactivity in the pooled AUC0-72 h and AUC96-336 h plasma, respectively. The most abundant radioactive peak (P7; M458) represented 0.10 and 43.92% of total radioactivity for pooled AUC0-72 and AUC96-336 h plasma, respectively. All other radioactive peaks accounted for less than 6% of the total plasma radioactivity and were not identified.

The majority of the radioactivity recovered in feces was associated with unchanged AG-881 (55.5% of the dose), while no AG-881 was detected in urine. In comparison, metabolites in excreta accounted for approximately 18% of dose in feces and for approximately 4% of dose in urine. M515, M460-1, M499, M516/M460-2, and M472/M476 were the most abundant metabolites in feces, and each accounted for approximately 2 to 5% of the radioactive dose, while M266 was the most abundant metabolite identified in urine and accounted for a mean of 2.54% of the dose. The remaining radioactive components in urine and feces each accounted for <1% of the dose.

Overall, the data presented indicate [14C]AG-881 underwent moderate metabolism after a single oral dose of 50-mg (100 μCi) and was eliminated in humans via a combination of metabolism and excretion of unchanged parent. AG-881 metabolism involved the oxidation and conjugation with glutathione (GSH) by displacement of the chlorine at the chloropyridine moiety. Subsequent biotransformation of GSH intermediates resulted in elimination of both glutamic acid and glycine to form the cysteinyl conjugates (M515 and M499). The cysteinyl conjugates were further converted by a series of biotransformation reactions such as oxidation, S-dealkylation, S-methylation, S-oxidation, S-acetylation and N-dealkylation resulting in the formation multiple metabolites.

A summary of the metabolites observed is included in Table 2

TABLE 2
Retention
ComponentTimeMatrix
designation(Minutes)[M + H]+Type of BiotransformationPlasmaUrineFeces
Unidentified 17.00UnknownX
M2667.67a267N-dealkylationX
Unidentified 2UnknownX
Unidentified 3UnknownX
Unidentified 4UnknownX
Unidentified 5UnknownX
M51519.79b516OxidationX
M460-120.76b461OxidationX
M49921.22b500Dechloro-glutathioneXX
conjugation + hydrolysis
M51621.89b517Oxidative-deaminationX
M460-221.98b461OxidationX
M47222.76b473S-dealkylation + S-X
acetylation + reduction
M47622.76b477OxidationX
Unidentified 6UnknownX
M47423.63b475OxidationX
Unidentified 7UnknownX
M43025.88b431AG-881-oxidationX
M42630.62b427S-dealkylation + methylationX
M45831.03c459AG-69460X*
AG-88139.41b415AG-881XX
M42847.40b429S-dealkylation + oxidationX
Table 3 contains a summary of protonated molecular ions and characteristic product ions for AG-881 and identified metabolites

TABLE 3
RetentionCharacteristic
MetaboliteTimeProposed MetaboliteProduct Ions
designation(Minutes)[M + H]+Identification(m/z)Matrix
M266 7.88a267[Figure (not displayed)]
188, 187Urine
M51519.79b516[Figure (not displayed)]
429, 260, 164, 153Feces
M460-120.76b461[Figure (not displayed)]
379, 260, 164Feces
M49921.22b500[Figure (not displayed)]
437, 413, 260, 164, 137Urine Feces
M51621.89b517[Figure (not displayed)]
427, 260, 164, 153Feces
M460-221.98b461[Figure (not displayed)]
369, 260, 164, 139, 121, 93Feces
M47222.76b473[Figure (not displayed)]
429, 260, 179, 164, 153Feces
M47622.76b477[Figure (not displayed)]
395, 260, 164, 139, 119Feces
M47423.63b475[Figure (not displayed)]
260, 164, 68Feces
M43025.88b431[Figure (not displayed)]
260, 164, 155, 68Feces
M42630.62b427[Figure (not displayed)]
260, 164, 151Feces
M45831.03b459[Figure (not displayed)]
380, 311, 260, 183, 164, 130Plasma Fecesd
AG-88139.41b415[Figure (not displayed)]
319, 277, 260, 240, 164, 139, 119, 68Plasma Fecesd
M42847.40b429[Figure (not displayed)]
260, 164, 153Feces
Notes
aRetention time from analysis of a urine sample
bRetention time from analysis of a feces sample
cRetention time from analysis of a plasma sample
dM458 was only detected in feces by mass spectrometry, not by radioprofiling.
The proposed (theoretical) biotransformation pathways leading to the observed metabolites are shown in FIG. 1.

Full text: Click here
Patent 2024
Acetylation AG 30 Biotransformation Chlorine Dealkylation Deamination Elements, Radioactive Feces Glutamic Acid Glutathione Glycine Healthy Volunteers High-Performance Liquid Chromatographies Homo sapiens Hydrolysis Intravenous Infusion Ions Liquid Chromatography Mass Spectrometry Metabolism Methylation Parent Plasma Radioactivity Retention (Psychology) Tandem Mass Spectrometry Urinalysis Urine vorasidenib

Example 1

95 g of manganese (purity: 99.95%; purchased from Taewon Scientific Co., Ltd.) and 5 g of high-purity graphite (purity: 99.5%; purchased from Taewon Scientific Co., Ltd.) were placed in a water-cooled copper crucible of an argon plasma arc melting apparatus (manufactured by Labold AG, Germany, Model: vacuum arc melting furnace Model LK6/45), and melted at 2,000 K under an argon atmosphere. The melt was cooled to room temperature at a cooling rate of 104 K/min to obtain an alloy ingot. The alloy ingot was crushed to a particle size of 1 mm or less by hand grinding. Thereafter, the obtained powders were magnetically separated using a Nd-based magnet to remove impurities repeatedly, and the Mn4C magnetic powders were collected. The collected Mn4C magnetic powders were subjected to X-ray diffraction (XRD) analysis (measurement system: D/MAX-2500 V/PO, Rigaku; measurement condition: Cu—Kα ray) and energy-dispersive X-ray spectroscopy (EDS) using FE-SEM (Field Emission Scanning Electron Microscope, MIRA3 LM).

FIGS. 2(a) and 2 (b) show an X-ray diffraction pattern and an energy-dispersive X-ray spectroscopy graph of the Mn4C magnetic material produced according to Example 1 of the present disclosure, respectively.

As can be seen in FIG. 2(a), the Mn4C magnetic material showed diffraction peaks of (111), (200), (220), (311) and (222) crystal planes at 2θ values of 40°, 48°, 69°, 82° and 88°, respectively, in the XRD analysis. Thus, it can be seen that the XRD patterns of the Mn4C magnetic material produced according to Example 1 are well consistent with the patterns of the cubic perovskite Mn4C. In addition, the Mn4C magnetic material shows several very weak diffraction peaks that can correspond to Mn23C6 and Mn. That is, the diffraction peak intensity at 2θ values of 43° and 44°, which correspond to Mn and Mn23C6 impurities, is as very low as about 2.5% of the diffraction intensity of the peak corresponding to the (111) plane. Through this, it can be seen that the powders obtained in Example 1 have high-purity Mn4C phase. The lattice parameter of the Mn4C is estimated to be about 3.8682 Å.

FIG. 2(b) shows the results of analyzing the atomic ratio of Mn:C in the powder by EDS. The atomic ratio of Mn:C is 80.62:19.38, which is very close to 4:1 within the experimental uncertainties. Thus, it can be seen that the powder is also confirmed to be Mn4C.

The M-T curve of the field aligned Mn4C powder obtained in Example 1 was measured under an applied field of 4 T and at a temperature ranging from 50 K to 400 K. Meanwhile, the M-T curve of the randomly oriented Mn4C powder was measured under an applied field of 1 T. The Curie temperature of Mn4C was measured under 10 mT while decreasing temperature from 930 K at a rate of 20 K/min.

FIGS. 3(a) to 3(c) show the M-T curves of the Mn4C magnetic material, produced according to Example 1 of the present disclosure, under magnetic fields of 4 T, 1 T, and 10 mT, respectively.

FIG. 3 shows magnetization-temperature (M-T) curves indicating the results of measuring the temperature-dependent magnetization intensity of the Mn4C magnetic material, produced in Example 1, using the vibrating sample magnetometer (VSM) mode of Physical Property Measurement System (PPMS®) (Quantum Design Inc.).

According to the Néel theory, the ferrimagnets that contain nonequivalent substructures of magnetic ions may have a number of unusual forms of M-T curves below the Curie temperature, depending on the distribution of magnetic ions between the substructures and on the relative value of the molecular field coefficients. The anomalous M-T curves of Mn4C, as shown in FIG. 3(a), can be explained to some extent by the Néel's P-type ferrimagnetism, which appears when the sublattice with smaller moment is thermally disturbed more easily. For Mn4C with two sublattices of MnI and MnII, as shown in FIG. 1, the MnI sublattice might have smaller moment.

FIG. 3(a) shows the temperature dependence of magnetization of the Mn4C magnetic material produced in Example 1. The magnetization of Mn4C measured at 4.2K is 6.22 Am2/kg (4 T), corresponding to 0.258μB per unit cell. The magnetization of the Mn4C magnetic material varies little at temperatures below 50 K, and is quite different from that of most magnetic materials, which undergo a magnetization deterioration with increasing temperature due to thermal agitation. Furthermore, the magnetization of the Mn4C magnetic material increases linearly with increasing temperature at temperatures above 50 K. The linear fitting of the magnetization of Mn4C at 4 T within the temperature range of 100 K to 400 K can be written as M=0.0072T+5.6788, where M and T are expressed in Am2/kg and K, respectively. Thus, the temperature coefficient of magnetization of Mn4C is estimated to be about ˜2.99*10−4μB/K per unit cell. The mechanisms of the anomalous thermomagnetic behaviors of Mn4C may be related to the magnetization competition of the two ferromagnetic sublattices (MnI and MnII) as shown in FIG. 1.

FIG. 3(b) shows the M-T curves of the Mn4C powders at temperatures within the range of 300 K to 930 K under 1 T. The linear magnetization increment stops at 590 K, above which the magnetization of Mn4C starts to decrease slowly first and then sharply at a temperature of about 860 K. The slow magnetization decrement at temperatures above 590 K is ascribed to the decomposition of Mn4C, which is proved by further heat-treatment of Mn4C as described below.

According to one embodiment of the present disclosure, the saturation magnetization of Mn4C increases linearly with increasing temperature within the range of 50 K to 590 K and remains stable at temperatures below 50 K. The increases in anomalous magnetization of Mn4C with increasing temperature can be considered in terms of the Néel's P-type ferrimagnetism. At temperatures above 590 K, the Mn4C decomposes into Mn23C6 and Mn, which are partially oxidized into the manganosite when exposed to air. The remanent magnetization of Mn4C varies little with temperature. The Curie temperature of Mn4C is about 870 K. The positive temperature coefficient (about 0.0072 Am2/kgK) of magnetization in Mn4C is potentially important in controlling the thermodynamics of magnetization in magnetic materials.

The Curie temperature Te of Mn4C is measured to be about 870 K, as shown in FIG. 3(c). Therefore, the sharp magnetization decrement of Mn4C at temperatures above 860 K is ascribed to both the decomposition of Mn4C and the temperature near the Tc of Mn4C.

FIG. 4 is a graph showing the magnetic hysteresis loops of the Mn4C magnetic material, produced according to Example 1 of the present disclosure, at 4.2 K, 200 K and 400 K. The magnetic hysteresis loops were measured by using the PPMS system (Quantum Design) under a magnetic field of 7 T while the temperature was changed from 4 K to 400 K.

As shown in FIG. 4, the positive temperature coefficient of magnetization was further proved by the magnetic hysteresis loops of Mn4C as shown in FIG. 4. The Mn4C shows a much higher magnetization at 400 K than that at 4.2 K. Moreover, the remanent magnetization of Mn4C varies little with temperature and is Δ3.5 Am2/kg within the temperature range of 4.2 K to 400 K. The constant remanent magnetization of Mn4C within a wide temperature range indicates the high stability of magnetization against thermal agitation. The coercivities of Mn4C at 4.2 K, 200 K, and 400 K were 75 mT, 43 mT, and 33 mT, respectively.

The magnetic properties of Mn4C measured are different from the previous theoretical results. A corner MnI moment of 3.85μB antiparallel to three face-centered MnII moments of 1.23μB in Mn4C was expected at 77 K. The net moment per unit cell was estimated to be 0.16μB. In the above experiment, the net moment in pure Mn4C at 77 K is 0.26μB/unit cell, which is much larger than that expected by Takei et al. It was reported that the total magnetic moment of Mn4C was calculated to be about 1μB, which is almost four times larger than the 0.258μB per unit cell measured at 4.2 K, as shown in FIG. 4.

FIG. 5 is an enlarged view of the temperature-dependent XRD patterns of the Mn4C magnetic material produced according to Example 1 of the present disclosure.

The thermomagnetic behaviors of Mn4C are related to the variation in the lattice parameters of Mn4C with temperature. It is known that the distance of near-neighbor manganese atoms plays an important role in the antiferro- or ferro-magnetic configurations of Mn atoms. Ferromagnetic coupling of Mn atoms is possible only when the Mn—Mn distance is large enough. FIG. 5 shows the diffraction peaks of the (111) and (200) planes of Mn4C at temperatures from 16 K to 300 K. With increasing temperature, both (111) and (200) peaks of Mn4C shifted to a lower degree at temperatures between 50 K and 300 K, indicating an enlarged distance of Mn—Mn atoms in Mn4C. No peak shift is obviously observed for Mn4C at temperatures below 50 K. The distance of nearest-neighbor manganese atoms plays an important role in the antiferro- or ferro-magnetic configurations of Mn atoms and thus has a large effect on the magnetic properties of the compounds.

Thus, it can be seen that the abnormal increase in magnetization of Mn4C with increasing temperature occurs due to the variation in the lattice parameters of Mn4C with temperature.

The powder produced in Example 1 was annealed in vacuum for 1 hour at each of 700 K and 923 K, and then subjected to X-ray spectroscopy, and the results thereof are shown in FIG. 6.

The magnetization reduction of Mn4C at temperatures above 590 K is ascribed to the decomposition of Mn4C, which is proved by the XRD patterns of the powders after annealing Mn4C at elevated temperatures. FIG. 6 shows the structural evolution of Mn4C at elevated temperatures. When Mn4C is annealed at 700 K, a small fraction of Mn4C decomposes into a small amount of Mn23C6 and Mn. The presence of manganosite is ascribed to the spontaneous oxidation of the Mn precipitated from Mn4C when exposed to air after annealing. The fraction of Mn23C6 was enhanced significantly for Mn4C annealed at 923 K, as shown in FIG. 6.

These results prove that the metastable Mn4C decomposes into stable Mn23C6 at temperatures above 590 K. The presence of Mn4C in the powder annealed at 923 K indicates a limited decomposition rate of Mn4C, from which the Tc of Mn4C can be measured. Both Mn23C6 and Mn are weak paramagnets at ambient temperature and elevated temperatures. Therefore, the magnetic transition of the Mn4C magnetic material at 870 K is ascribed to the Curie point of the ferrimagnetic Mn4C.

The Mn4C shows a constant magnetization of 0.258μB per unit cell below 50 K and a linear increment of magnetization with increasing temperature within the range of 50 K to 590 K, above which Mn23C6 precipitates from Mn4C. The anomalous M-T curves of Mn4C can be considered in terms of the Néel's P-type ferrimagnetism.

Full text: Click here
Patent 2024
Alloys Argon Atmosphere Biological Evolution Cells Copper Cuboid Bone Debility Energy Dispersive X Ray Spectroscopy Face Fever fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether Graphite Ions Magnetic Fields Manganese perovskite Physical Processes Plasma Powder Radiography Scanning Electron Microscopy Spectrum Analysis Vacuum Vision X-Ray Diffraction
Not available on PMC !

Example 16

Direct analysis of chemicals in animal tissue using probes of the invention was performed as shown in FIG. 29A. A small sections of tissue were removed and placed on a paper triangle. Methanol/water (1:1 v:v; 10 μl) was added to the paper as solvent and then 4.5 kV positive DC voltage was applied to produce the spray for MS analysis. Protonated hormone ions were observed for porcine adrenal gland tissue (1 mm3, FIG. 29B). FIG. 16 is a mass spectrum showing direct analysis of hormones in animal tissue by paper spray. A small piece of pig adrenal gland tissue (1 mm×1 mm×1 mm) was placed onto the paper surface, MeOH/water (1:1 v:v; 10 μl) was added and a voltage applied to the paper to produce a spray. The hormones epinephrine and norepinephrine were identified in the spectrum; at high mass the spectrum was dominated by phospolipid signals.

Lipid profiles were obtained for human prostate tissues (1 mm2×15 μm, FIGS. 29C and 29D) removed from the tumor and adjacent normal regions. Phospholipids such as phosphatidylcholine (PC) and sphingomyelin (SM) were identified in the spectra. The peak of [PC(34:1)+K]+ at m/z 798 was significantly more intense in tumor tissue (FIG. 29C) and peaks [SM(34:1)+Na]+ at m/z 725, [SM(36:0)+Na]+ at m/z 756, and [SM(36:4)+Na]+ at m/z 804 were significantly lower compared with normal tissue (FIG. 29D).

Full text: Click here
Patent 2024
Adrenal Glands Animals Epinephrine Homo sapiens Hormones Ions Lipids Mass Spectrometry Methanol Neoplasms Norepinephrine Phosphatidylcholines Phospholipids Pigs Prostate Solvents Sphingomyelins Tissues

Example 3

Penicillium roqueforti spores were suspended in water. Four DEE chemical compositions were evaluated: (1) 0.06 M copper (II) ions in water, (2) 1 wt.-% surfactant and 10 wt.-% PCSR, (3) 1 wt.-% surfactant and 1 wt.-% PCSR, and (4) 0.5 wt.-% bleach. OxiClean was used as the PCSR and Tween 80 as the surfactant. Clorox was used as bleach. Each DEE composition was added to 0.1 mg/ml suspension of mold spores and exposed to 2.45 GHz microwave for 10 s. After exposure, the cells were centrifuged, washed to remove the DEE chemicals and then plated on Petrifilm and cultured. With the DEE composition 0.06 M copper (II) ions in water and 1 wt.-% surfactant and 10 wt.-% sodium percarbonate, a 6-7 log reduction in P. roqueforti spores (6-7 log kill levels) was realized.

Full text: Click here
Patent 2024
Cells chemical composition Clorox Copper Fungus, Filamentous Ions Microwaves Penicillium roqueforti sodium percarbonate Spores Surface-Active Agents Tween 80

Top products related to «Ions»

Sourced in United States, Germany, China, United Kingdom, Japan, Denmark, Uruguay
The Q Exactive mass spectrometer is a high-resolution, accurate-mass (HRAM) instrument designed for advanced proteomics, metabolomics, and small molecule applications. It combines a quadrupole mass filter with a high-field Orbitrap mass analyzer to provide precise mass measurements and high-quality data.
Sourced in United States, Germany, United Kingdom, Japan, China, France, Denmark, Italy, Spain
The Q Exactive is a high-resolution mass spectrometer designed for accurate and sensitive analysis of a wide range of samples. It features a quadrupole mass filter and an Orbitrap mass analyzer, providing high-resolution, accurate mass measurements for qualitative and quantitative applications.
Sourced in United States, Germany, United Kingdom, Austria, China
Proteome Discoverer is a software solution for the analysis of mass spectrometry-based proteomic data. It provides a comprehensive platform for the identification, quantification, and characterization of proteins from complex biological samples.
Sourced in United States, Germany, Denmark, Japan
The EASY-nLC 1000 is a high-performance liquid chromatography (nanoLC) system designed for sensitive and reproducible separation of complex peptide mixtures. It offers precise solvent delivery, robust performance, and compatibility with a range of detectors, making it a versatile tool for proteomics research and analysis.
Sourced in United States, Germany, United Kingdom, Canada
The Q Exactive HF is a high-resolution, accurate-mass (HR-AM) mass spectrometer designed for a wide range of applications. It features a high-field Orbitrap mass analyzer that provides high mass resolution and mass accuracy. The Q Exactive HF can perform full-scan MS and tandem MS (MS/MS) experiments to facilitate the identification and quantification of compounds.
Sourced in United States, Germany, Japan, China, France, United Kingdom
The Q Exactive Plus is a high-resolution, accurate-mass Orbitrap mass spectrometer designed for a wide range of applications, including proteomics, metabolomics, and small molecule analysis. It features high-performance mass analysis, with a mass resolution up to 280,000 FWHM at m/z 200 and mass accuracy of less than 1 ppm.
Sourced in United States, United Kingdom, Germany
Proteome Discoverer 1.4 is a software application designed for the analysis and identification of proteins in mass spectrometry data. It provides a platform for processing, analyzing, and interpreting proteomics data.
Sourced in United States, Germany, Italy, United Kingdom, France, Japan
Xcalibur is a software package developed by Thermo Fisher Scientific for the control and management of mass spectrometry instrumentation. It provides a comprehensive suite of tools for data acquisition, processing, and analysis. The software's core function is to enable users to operate and interact with Thermo Fisher Scientific's mass spectrometry systems.
Sourced in United States, Germany, United Kingdom, France, Italy, Uruguay, Japan
The LTQ Orbitrap XL is a high-resolution mass spectrometer designed for advanced research applications. It combines a linear ion trap mass analyzer with a high-field Orbitrap mass analyzer, providing accurate mass measurements and high-resolution capabilities.
Sourced in United States, Germany, United Kingdom, France, China, Japan, Italy, Austria, Switzerland, Denmark
The Thermo Scientific™ Ultimate 3000 is a high-performance liquid chromatography (HPLC) system designed for a wide range of analytical applications. It features a modular design, allowing for customization to meet specific laboratory needs.

More about "Ions"

Ions, also known as charged particles or electrolytes, are essential components in various biological processes within the human body.
These charged atoms or molecules play crucial roles in nerve impulse transmission, muscle contraction, fluid balance regulation, and the structure and function of proteins, enzymes, and other biomolecules.
Cations, or positively charged ions, and anions, or negatively charged ions, work together to maintain homeostasis and support vital physiological functions.
Imbalances in ion concentrations, which can be detected and analyzed using advanced mass spectrometry techniques like the Q Exactive, Q Exactive HF, and LTQ Orbitrap XL, can lead to a wide range of health issues, making the study of ions a key focus of medical research.
The EASY-nLC 1000 and Proteome Discoverer software, along with the Xcalibur platform, are commonly used in ion-related research to separate, identify, and quantify various ionic species and their interactions with biomolecules.
Understanding the role of ions in both normal and pathological conditions is crucial for developing effective treatments and maintaining overall health and well-being.
Ions, such as sodium, potassium, calcium, and chloride, are essential for processes like nerve impulse propagation, muscle contraction, and fluid balance.
Imbalances in these ions can result in conditions like hypertension, arrhythmias, and electrolyte disorders.
Researchers leverage advanced mass spectrometry techniques and bioinformatics tools like Proteome Discoverer 1.4 to study the complex interplay of ions and their impact on human physiology and pathology.
This comprehensive overview highlights the importance of ions in the human body and the ongoing research efforts to understand their crucial roles in maintaining optimal health.
By studying the intricate mechanisms involving ions, scientists can develop better diagnostic and therapeutic strategies to address a wide range of health concerns.